16-55492964-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_004530.6(MMP2):c.1337-194G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.364 in 151,968 control chromosomes in the GnomAD database, including 10,109 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.36 ( 10109 hom., cov: 31)
Consequence
MMP2
NM_004530.6 intron
NM_004530.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.960
Publications
3 publications found
Genes affected
MMP2 (HGNC:7166): (matrix metallopeptidase 2) This gene is a member of the matrix metalloproteinase (MMP) gene family, that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A, type IV collagenase, that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members, activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases, or, intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system, endometrial menstrual breakdown, regulation of vascularization, and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
MMP2 Gene-Disease associations (from GenCC):
- multicentric osteolysis, nodulosis, and arthropathyInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- multicentric osteolysis-nodulosis-arthropathy spectrumInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 16-55492964-G-A is Benign according to our data. Variant chr16-55492964-G-A is described in ClinVar as Benign. ClinVar VariationId is 1251050.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.38 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MMP2 | NM_004530.6 | c.1337-194G>A | intron_variant | Intron 8 of 12 | ENST00000219070.9 | NP_004521.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.364 AC: 55242AN: 151848Hom.: 10105 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
55242
AN:
151848
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.364 AC: 55259AN: 151968Hom.: 10109 Cov.: 31 AF XY: 0.367 AC XY: 27256AN XY: 74288 show subpopulations
GnomAD4 genome
AF:
AC:
55259
AN:
151968
Hom.:
Cov.:
31
AF XY:
AC XY:
27256
AN XY:
74288
show subpopulations
African (AFR)
AF:
AC:
13685
AN:
41442
American (AMR)
AF:
AC:
4810
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1586
AN:
3462
East Asian (EAS)
AF:
AC:
1470
AN:
5162
South Asian (SAS)
AF:
AC:
1866
AN:
4818
European-Finnish (FIN)
AF:
AC:
4736
AN:
10542
Middle Eastern (MID)
AF:
AC:
85
AN:
294
European-Non Finnish (NFE)
AF:
AC:
26059
AN:
67950
Other (OTH)
AF:
AC:
698
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1783
3566
5350
7133
8916
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
540
1080
1620
2160
2700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1088
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.